Skip Navigation
ChemIDplus A TOXNET DATABASE Lite•Browse•Advanced

Substance Name: Picoperine hydrochloride
RN: 24699-40-9
UNII: 2142K55R4Y
InChIKey: MSVZUEGLXXVUJS-UHFFFAOYSA-N

Classification Codes

  • Drug / Therapeutic Agent
  • Reproductive Effect

Molecular Formula

  • C19-H25-N3.Cl-H

Molecular Weight

  • 331.888
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Picoperine hydrochloride

Synonyms

  • 1-(2-(N-(2-Pyridylmethyl)anilino)ethyl)piperidine hydrochloride
  • 1-(2-(Phenyl(2-pyridylmethyl)amino)ethyl)piperidine hydrochloride
  • 2-Pyridinemethanamine, N-phenyl-N-(2-(1-piperidinyl)ethyl)-, monohydrochloride
  • Coben
  • N-(2-Picolyl)-N-phenyl-N-(2-piperidinoethyl)amine hydrochloride
  • N-(2-Piperidinoethyl)-N-(2-pyridylmethyl)aniline hydrochloride
  • N-(2-Pyridylmethyl)-N-phenyl-N-2-(piperidinoethyl)amine hydrochloride
  • N-Phenyl-N-(2-pyridylmethyl)-2-piperidinoethylamine hydrochloride
  • Picoperidamine hydrochloride
  • Picoperine HCl
  • Picoperine hydrochloride
  • Piperidine, 1-(2-(N-(2-pyridylmethyl)anilino)ethyl)-, monohydrochloride
  • TAT-3 hydrochloride
  • UNII-2142K55R4Y

Systematic Name

  • Piperidine, 1-(2-(N-(2-pyridylmethyl)anilino)ethyl)-, hydrochloride

Registry Numbers

CAS Registry Number

  • 24699-40-9

FDA UNII

  • 2142K55R4Y

Other Registry Number

  • 21755-67-9

Related Registry Number

  • 21755-66-8 (Parent)

System Generated Number

  • 0024699409

Molecular Formulas

Molecular Formula

  • C19-H25-N3.Cl-H

Molecular Formula Fragments

  • C19-H25-N3
  • Cl-H
  • COMPONENT

Structure Descriptors

InChI

1S/C19H25N3.ClH/c1-3-10-19(11-4-1)22(17-18-9-5-6-12-20-18)16-15-21-13-7-2-8-14-21;/h1,3-6,9-12H,2,7-8,13-17H2;1H

InChIKey

MSVZUEGLXXVUJS-UHFFFAOYSA-N

Smiles

c1(ccccn1)CN(CCN1CCCCC1)c1ccccc1.Cl

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LDLo intravenous 25mg/kg (25mg/kg) GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: CYANOSIS		 Arzneimittel-Forschung. Drug Research. Vol. 19, Pg. 1916, 1969.
dog LDLo oral 100mg/kg (100mg/kg) GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: CYANOSIS		 Arzneimittel-Forschung. Drug Research. Vol. 19, Pg. 1916, 1969.
mouse LD50 intraperitoneal 55500ug/kg (55.5mg/kg)   Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 403, 1970.
mouse LD50 intravenous 10mg/kg (10mg/kg)   Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 403, 1970.
mouse LD50 oral 195mg/kg (195mg/kg)   Takeda Kenkyusho Ho. Journal of the Takeda Research Laboratories. Vol. 29, Pg. 310, 1970.
mouse LD50 subcutaneous 142mg/kg (142mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 403, 1970.
rat LD50 intraperitoneal 69mg/kg (69mg/kg)   Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 403, 1970.
rat LD50 intravenous 11500ug/kg (11.5mg/kg)   Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 403, 1970.
rat LD50 oral 740mg/kg (740mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: EXCITEMENT		 Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 403, 1970.
rat LD50 subcutaneous 480mg/kg (480mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 403, 1970.